Castle Biosciences Inc. (CSTL) Tops Q3 EPS by 50c

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q3 EPS of ($0.26), $0.50 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $61.5 million versus the consensus estimate of $48.56 million.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Adobe (ADBE) PT Raised to $250 at Baird
• KeyBanc Starts PPG Industries (PPG) at Overweight